NINGBO INNO PHARMCHEM CO.,LTD. is a leading provider of high-quality pharmaceutical intermediates, understanding the critical impact these compounds have on the drug development pipeline. Among our portfolio, 2-Chloro-4-amino-6,7-dimethoxyquinazoline (CAS 23680-84-4) plays a particularly significant role. This chemical entity serves as an essential intermediate in the synthesis of several vital medications, primarily within the class of alpha-blockers, which are widely used to treat conditions such as hypertension and symptoms of benign prostatic hyperplasia.

The molecular formula of this compound is C10H10ClN3O2, with a molecular weight of 239.66. Its designation as an 'intermediate' signifies its crucial position in a multi-step chemical process, acting as a foundational building block for more complex Active Pharmaceutical Ingredients (APIs). The synthesis of prazosin, doxazosin, terazosin, and alfuzosin all rely on the availability of this specific quinazoline derivative. The precise chemical structure and the high purity, often exceeding 99.5%, are critical for ensuring the efficacy, safety, and consistency of these vital drugs. The demand for alpha-blocker synthesis thus directly drives the market for this intermediate.

For pharmaceutical companies, sourcing reliable intermediates is a strategic imperative. The consistent production of 2-chloro-4-amino-6,7-dimethoxyquinazoline ensures that manufacturing processes for essential medicines can proceed without interruption. This reliability is paramount for companies that need to buy this compound for their production lines. At NINGBO INNO PHARMCHEM CO.,LTD., we prioritize stringent quality control measures at every stage of production to guarantee that our pharmaceutical intermediates meet the highest industry standards. This commitment ensures that our clients can confidently integrate our products into their complex synthesis routes for alpha-blocker drugs.

The significance of intermediates like 2-chloro-4-amino-6,7-dimethoxyquinazoline extends beyond their direct use in manufacturing. They are also critical tools in pharmaceutical research and development. Scientists exploring new drug candidates or seeking to optimize existing formulations often utilize such well-characterized building blocks. The quinazoline scaffold itself is of great interest in medicinal chemistry, offering a versatile platform for developing novel therapeutic agents. The accessibility of this intermediate facilitates ongoing innovation in drug discovery, potentially leading to new treatments for a range of medical conditions.

In conclusion, 2-chloro-4-amino-6,7-dimethoxyquinazoline (CAS 23680-84-4) is a critical intermediate in the pharmaceutical industry. Its role in the synthesis of essential alpha-blocker medications underscores its importance in modern healthcare. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing this high-quality compound, supporting the pharmaceutical sector's efforts to develop and deliver life-improving therapies to patients worldwide. The consistent demand for alpha-blocker synthesis makes this a key chemical for the industry.